Clinical Trial Update: Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating cangrelor in comatose OHCA survivors undergoing primary PCI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Out-of-hospital Cardiac Arrest

Drugs mentioned

• Cangrelor (cangrelor)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Out-Of-Hospital Cardiac Arrest, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED